Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
2.240
-0.050 (-2.18%)
At close: Mar 19, 2026, 4:00 PM EDT
2.250
+0.010 (0.45%)
After-hours: Mar 19, 2026, 7:58 PM EDT
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
|---|
Research, Development and Commercialization of its Novel Gene Therapies | 4.41M | 4.05M | 6.04M | 2.49M | | 43.00K | | | |
Research, Development and Commercialization of its Novel Gene Therapies Growth | 8.83% | -32.82% | 142.60% | - | | - | | | |
| 4.41M | 4.05M | 6.04M | 2.49M | | 43.00K | | | |
| 8.83% | -32.82% | 142.60% | - | | - | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
|---|
| 4.41M | 4.05M | 6.04M | 2.49M | | 43.00K | | | |
| 8.83% | -32.82% | 142.60% | - | | - | | | |
| 4.41M | 4.05M | 6.04M | 2.49M | | 43.00K | | | |
| 8.83% | -32.82% | 142.60% | - | | - | | | |
Source: S&P Global Market Intelligence.
